The objective analysis helps dentists know where to take a deeper look so they can provide comprehensive patient care. The software also reviews the past 18 months of X-rays of every patient in the practice and cross-references with the treatment plans on file to identify patients with potentially undiagnosed conditions.
"Canada is one of the leading countries in AI and technology adoption, and we look forward to bringing Overjet to Canada to enhance oral health," said Wardah Inam, PhD, the CEO and co-founder of Overjet. "We look forward to working with our Canadian partners to create a future that is clinically-precise, efficient, and patient-centric."
"It's an honor to have the opportunity to introduce AI technology to advance patient care in the country where I grew up," said Chris Balaban, DMD, VP of Clinical Affairs at Overjet. "Overjet not only provides data-driven insights to help dentists determine the right treatment at the right time, but it helps educate and empower patients to make more informed decisions about their oral and overall health."
In the United States, Overjet has been cleared by the Food and Drug Administration and is used by dental support organizations (DSOs), independent dentists, and dental insurance carriers, representing more than 100 million patients.
Canadian providers, payers, and industry partners seeking more information are urged to visit: overjet.com.